[Therapy of osteoporosis using the ADFR schedule (especially with parathyroid hormone and etidronate)].
Ziegler
R
R
Abteilung für Innere Medizin I (Endokrinologie und Stoffwechsel), Medizinische Universitätsklinik, Heidelberg.
D000368:Aged; D015519:Bone Density / Q000187:drug effects; D002116:Calcitonin / Q000008:administration & dosage; D004164:Diphosphonates / Q000008:administration & dosage; D004334:Drug Administration Schedule; D004359:Drug Therapy, Combination; D012968:Etidronic Acid / Q000008:administration & dosage; D005260:Female; D006801:Humans; D008875:Middle Aged; D010010:Osteoclasts / Q000187:drug effects; D010024:Osteoporosis / Q000188:drug therapy*; D015663:Osteoporosis, Postmenopausal / Q000188:drug therapy*; D010281:Parathyroid Hormone / Q000008:administration & dosage*
D004164:Diphosphonates; D010281:Parathyroid Hormone; D002116:Calcitonin; D012968:Etidronic Acid
Osteoporosetherapie nach dem ADFR-Schema (insbesondere mit Parathormon bzw. Etidronat).